Hostname: page-component-586b7cd67f-2plfb Total loading time: 0 Render date: 2024-11-25T08:10:10.088Z Has data issue: false hasContentIssue false

The Impact of Recurrent Clostridium difficile Infection on Patients’ Prevention Behaviors

Published online by Cambridge University Press:  26 September 2017

Frances M. Weaver*
Affiliation:
Public Health Sciences, Loyola University, Chicago, Illinois Center of Innovation for Complex Chronic Healthcare (CINCCH), Hines Veterans Affairs Hospital, Hines, Illinois
William E. Trick
Affiliation:
Department of Medicine, Cook County Health & Hospitals System, Rush University Medical Center, Chicago, Illinois
Charlesnika T. Evans
Affiliation:
Center of Innovation for Complex Chronic Healthcare (CINCCH), Hines Veterans Affairs Hospital, Hines, Illinois Department of Preventive Medicine, Northwestern University, Chicago, Illinois
Michael Y. Lin
Affiliation:
Center for Health Care Studies, Institute for Public Health and Medicine, Northwestern University, Chicago, Illinois Division of Infectious Diseases, Rush University Medical Center, Chicago, Illinois
William Adams
Affiliation:
Health Sciences Division, Loyola University, Maywood, Illinois
Mai T. Pho
Affiliation:
Division of Infectious Diseases and Global Health, Department of Medicine, University of Chicago, Chicago, Illinois
Susan C. Bleasdale
Affiliation:
Division of Infectious Diseases, College of Medicine, University of Illinois at Chicago, Chicago, Illinois Department of Medicine, Jesse Brown Veterans Affairs Medical Center, Chicago, Illinois
Kathleen M. Mullane
Affiliation:
Division of Infectious Diseases and Global Health, Department of Medicine, University of Chicago, Chicago, Illinois
Stuart Johnson
Affiliation:
Division of Infectious Diseases, Loyola University Medical Center, Chicago, Illinois Research Service and Infectious Disease Section, Edward Hines, Jr., Veterans Affairs Hospital, Hines, Illinois
Monica K. Sikka
Affiliation:
Division of Infectious Diseases, College of Medicine, University of Illinois at Chicago, Chicago, Illinois Department of Medicine, Jesse Brown Veterans Affairs Medical Center, Chicago, Illinois
Lance R. Peterson
Affiliation:
Department of Clinical Microbiology and Infectious Diseases, NorthShore University Health System, Evanston, Illinois
Anthony E. Solomonides
Affiliation:
Department of Family Medicine, NorthShore University Health System, Evanston, Illinois Ambulatory Primary Care Innovations Group, NorthShore University Health System, Evanston, Illinois
Dale N. Gerding
Affiliation:
Edward Hines, Jr., Veterans Affairs Hospital, Hines, Illinois
*
Address correspondence to Frances M. Weaver, PhD, Public Health Sciences, Loyola University Health Sciences Campus, 2150 S First Ave, Maywood, IL 60152 ([email protected]).

Abstract

OBJECTIVE

To determine the impact of recurrent Clostridium difficile infection (RCDI) on patient behaviors following illness.

METHODS

Using a computer algorithm, we searched the electronic medical records of 7 Chicago-area hospitals to identify patients with RCDI (2 episodes of CDI within 15 to 56 days of each other). RCDI was validated by medical record review. Patients were asked to complete a telephone survey. The survey included questions regarding general health, social isolation, symptom severity, emotional distress, and prevention behaviors.

RESULTS

In total, 119 patients completed the survey (32%). On average, respondents were 57.4 years old (standard deviation, 16.8); 57% were white, and ~50% reported hospitalization for CDI. At the time of their most recent illness, patients rated their diarrhea as high severity (58.5%) and their exhaustion as extreme (30.7%). Respondents indicated that they were very worried about getting sick again (41.5%) and about infecting others (31%). Almost 50% said that they have washed their hands more frequently (47%) and have increased their use of soap and water (45%) since their illness. Some of these patients (22%–32%) reported eating out less, avoiding certain medications and public areas, and increasing probiotic use. Most behavioral changes were unrelated to disease severity.

CONCLUSION

Having had RCDI appears to increase prevention-related behaviors in some patients. While some behaviors are appropriate (eg, handwashing), others are not supported by evidence of decreased risk and may negatively impact patient quality of life. Providers should discuss appropriate prevention behaviors with their patients and should clarify that other behaviors (eg, eating out less) will not affect their risk of future illness.

Infect Control Hosp Epidemiol. 2017;38:1351–1357

Type
Original Articles
Copyright
© 2017 by The Society for Healthcare Epidemiology of America. All rights reserved 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1. Bassetti, M, Villa, G, Pecori, D, Arzese, A, Wilcox, M. Epidemiology, diagnosis and treatment of Clostridium difficile infection. Expert Rev Anti Infect Ther 2012;10:14051423.Google Scholar
2. Shields, K, Araujo-Castillo, RV, Theethira, TG, Alonso, CD, Kelly, CP. Recurrent Clostridium difficile infection: from colonization to cure. Anaerobe 2015;34:5973.Google Scholar
3. Sheitoyan-Pésant, C, Abou, C, Pepin, J, Marcil-Héguy, A, Nault, VI, Valliquette, L. Clinical and healthcare burden of multiple recurrences of Clostridium difficile infection. Clin Infect Dis 2016;62:574580.Google Scholar
4. Shah, DN, Aitken, SL, Barragan, LE, et al. Economic burden of primary compared with recurrent Clostridium difficile infection in hospitalized patients: a prospective cohort study. J Hosp Infect 2016;93:286289.Google Scholar
5. Desai, K, Gupta, SB, Dubberke, ER, et al. Epidemiological and economic burden of Clostridium difficile in the United States: estimates from a modeling approach. BMC Infect Dis 2016;16:303.Google Scholar
6. Cohen, SH, Gerding, DN, Johnson, S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of American (ISDA). Infect Control Hosp Epidemiol 2010;31:431455.Google Scholar
7. Madeo, M, Boyack, M. Using the lived experiences of patients with Clostridium difficile infection to improve care. Nursing Times 2010;106:1013.Google Scholar
8. Guillemin, I, Marrel, A, Lambert, J, et al. Patients’ experience and perception of hospital-treated Clostridium difficile infections: a qualitative study. Patient-Patient-Cent Outcome Res 2014;7:97105.CrossRefGoogle ScholarPubMed
9. Solomonides, A, Goel, S, Hynes, D, et al. Patient-centered outcomes research in practice: The CAPRiCORN infrastructure. Stud Health Technol Inform 2015;216:584588.Google ScholarPubMed
10. Bauer, MP, Kujiper, EJ, Van Dissel, JT. European Society of clinical microbiology and infectious diseases (ESCMID): treatment guidance for Clostridium difficile infection (CDI). Clin Microbiol Infect 2009;15:10671079.Google Scholar
11. Agresti, A. Analysis of Ordinal Categorical Data. DeKalb, IL: John Wiley & Sons; 2010.Google Scholar
12. Kuntz, JL, Baker, JM, Kipnis, P, Li, SX, Liu, V, Xie, Y, Marcella, S, Escobar, GJ. Utilization of health services among adults with recurrent Clostridium difficile infection: A 12-year population-based study. Infect Control Hosp Epidemiol 2017;38:4552.Google Scholar
13. Garey, KW, Sethi, S, Yadav, Y, DuPont, HL. Meta-analysis to assess risk factors for recurrent Clostridium difficile infection. J Hosp Infect 2008;70:298304.Google Scholar
14. APIC Implementation Guideline . Guide to Preventing Clostridium difficile Infections. Washington, DC: Association for Professionals in Infection Control and Epidemiology; 2013.Google Scholar
15. Rodriguez, LA, Ruigomez, A. Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study. BMJ 1999;318:565566.CrossRefGoogle ScholarPubMed
16. Moore, JH, Pinheiro, CCD, Zaenker, EI, et al. Defined nutrient diets alter susceptibilitiy to Clostridium difficile associated disease in a murine model. PLOS ONE 2015;10(9):e0137037.Google Scholar
17. Scott, KG, Logan, MR, Klammer, GM, Teoh, DA, Buret, AG. Jejunal brush border microvillous alterations in giardia muris-infected mice: role of T lymphocytes and interleukin-6. Infect Immun 2000;68:34123418.Google Scholar
18. McDonald, EG, Milligan, J, Frenette, C, Lee, TC. Continuous proton pump inhibitor therapy and the associated risk of recurrent Clostridium difficile infection. JAMA Intern Med 2015;175:784791.Google Scholar
19. Freedberg, DE, Lamousé-Smith, ES, Lightdale, JR, Jin, Z, Yang, YX, Abrams, JA. Use of acid suppression medication is associated with risk for C. difficile infection in infants and children: a population-based study. Clin Infect Dis 2015;61:912917.Google Scholar
20. Kwok, CS, Arthur, AK, Anibueze, CI, Singh, S, Cavallazzi, R, Loke, YK. Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis. Am J Gastroenterol 2012;107:10111019.Google Scholar
21. Goldenberg, JZ, Ma, SSY, Saxton, JD, et al. Probiotics for the prevention of Clostridium difficile–associated diarrhea in adults and children (review). Cochrane Database Syst Rev 2013;5:1153.Google Scholar
22. Johnson, S, Maziade, PJ, McFarland, LV, et al. Is primary prevention of Clostridium difficile infection possible with specific probiotics? Int J Infect Dis 2012;16:e786e792.CrossRefGoogle ScholarPubMed
23. Evans, CT, Johnson, S. Prevention of Clostridium difficile infection with probiotics. Clin Infect Dis 2015;60:S122S128.Google Scholar
24. Chang, JY, Antonopoulos, DA, Kalra, A, et al. Decreased diversity of the fecal microbiome in recurrent Clostridium difficile–associated diarrhea. J Infect Dis 2008;197:435438.CrossRefGoogle ScholarPubMed
Supplementary material: File

Weaver supplementary material

Weaver supplementary material 1

Download Weaver supplementary material(File)
File 13.7 KB
Supplementary material: File

Weaver supplementary material

Weaver supplementary material 2

Download Weaver supplementary material(File)
File 51.9 KB